drug safety

two green lights
Biotech

CytomX reports patient death from kidney injury in ADC trial

A patient has died from kidney injury in a trial of CytomX’s lead ADC, although the biotech has been advised to stick with the study.
James Waldron Aug 14, 2025 6:45am
Graphic of a fork in the road with arrows pointing in either direction
Favicon Fierce Pharma

Prasad exit signals more permissive FDA for cell and gene field

Jul 31, 2025 9:10am
sarepta building
Favicon Fierce Pharma

FDA backtracks on Sarepta's gene therapy Elevidys in DMD

Jul 28, 2025 6:02pm
FDA
Favicon Fierce Pharma

FDA eyeing study requirements to confirm Elevidys safety: report

Jul 24, 2025 3:12pm
Sarepta Sarepta Therapeutics
Favicon Fierce Pharma

Sarepta will continue shipping Elevidys despite FDA misgivings

Jul 21, 2025 10:42am
Sarepta Sarepta Therapeutics

Sarepta faces new scrutiny after 3rd patient death

Jul 18, 2025 10:19am